Several reports have shown the association between the IL17B/IL17RB signaling pathway and tumor development in breast, gastric, lung, pancreas, prostate, brain and blood cancers, however the precise mechanisms involved remain unclear [23,24,25,26]. Here, IL17RB is linked to neoplasm.